SynthesisTargeted oncology2020

Efficacy and Safety of Crizotinib in the Treatment of Advanced Non-Small-Cell Lung Cancer with ROS1 Rearrangement or MET Alteration: A Systematic Review and Meta-Analysis.

Huy Gia Vuong et al.PubMed ↗Publisher ↗

No numbers read from the abstract.